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Summary
Multiple sclerosis is the most common cause of non-traumatic neurological impairment in young
adults. An energy deficient state has been implicated in the degeneration of axons, the
pathological correlate of disease progression, in multiple sclerosis. Mitochondria are the most
efficient producers of energy and play an important role in calcium homeostasis. We analysed the
density and function of mitochondria using immunohistochemistry and histochemistry,
respectively, in chronic active and inactive lesions in progressive multiple sclerosis. As shown
before in acute pattern III and Balo’s lesions, the mitochondrial respiratory chain complex IV
activity is reduced despite the presence of mitochondria in demyelinated axons with amyloid
precursor protein accumulation, which are predominantly located at the active edge of chronic
active lesions. Furthermore, the strong non-phosphorylated neurofilament (SMI32) reactivity was
associated with a significant reduction in complex IV activity and mitochondria within
demyelinated axons. The complex IV defect associated with axonal injury may be mediated by
soluble products of innate immunity, as suggested by an inverse correlation between complex IV
activity and macrophage/microglial density in chronic lesions. However, in inactive areas of
chronic multiple sclerosis lesions the mitochondrial respiratory chain complex IV activity and
mitochondrial mass, judged by porin immunoreactivity, are increased within approximately half of
large (>2.5 μm diameter) chronically demyelinated axons compared with large myelinated axons
in the brain and spinal cord. The axon-specific mitochondrial docking protein (syntaphilin) and
phosphorylated neurofilament-H were increased in chronic lesions. The lack of complex IV
activity in a proportion of Na+/K+ ATPase α-1 positive demyelinated axons supports axonal
dysfunction as a contributor to neurological impairment and disease progression. Furthermore, in
vitro studies show that inhibition of complex IV augments glutamate-mediated axonal injury
(amyloid precursor protein and SMI32 reactivity). Our findings have important implications for
both axonal degeneration and dysfunction during the progressive stage of multiple sclerosis.
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Introduction
Multiple sclerosis is the most common non-traumatic neurological disease among young
adults in Europe and North America (Compston, 2005). Over two-thirds of patients develop
progressive deterioration in neurological function. Whilst currently available
immunomodulatory therapy is effective in reducing the rate of relapses in the disease, its
progression remains unaltered by such agents (Ebers et al., 2008). The degeneration of
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demyelinated axons is considered as the pathological correlate of disease progression (Dutta
and Trapp, 2007). The recently identified changes in electrogenic machinery in chronically
demyelinated axons suggest that axonal dysfunction, a well recognized and positively
reversible entity during relapsing remitting phase, may also contribute to the disability in the
late stages of multiple sclerosis (Black et al., 2007; Waxman, 2008; Young et al., 2008).
Following demyelination and subsequent loss of saltatory conduction, the axonal membrane
undergoes a number of changes including an increase in number of sodium channels within
the demyelinated part of the axon (Craner et al., 2004; Waxman, 2006a; Black et al., 2007;
Smith, 2007). The maintenance of intra-axonal ionic balance and resting membrane potential
following the influx of sodium through the increased sodium channels relies on the largest
consumer of energy in the central nervous system, Na+/K+ ATPase (Caldwell et al., 1960;
Ames, 2000). In non-inflammatory environments this increase in energy demand of axons
lacking a healthy myelin sheath is apparent by the changes in density and activity of energy
producing organelles (mitochondria) in shiverer mice with a defect in the myelin basic
protein (MBP) gene as well as unmyelinated segments of retinal ganglion cell axons in the
lamina cribrosa of control optic nerves (Bristow et al., 2002; Barron et al., 2004; Andrews et
al., 2006).
Mitochondria are the most efficient producers of ATP and play a role in apoptosis, reactive
oxygen species generation and calcium buffering (DiMauro and Schon, 2003; Andreyev et
al., 2005; Rizzuto and Pozzan, 2006). An imbalance of intra-axonal calcium appears to be
involved in the degeneration of axons following a number of insults including ischaemia,
trauma and possibly inflammation (Waxman et al., 1992; Coleman, 2005; Stys, 2005). The
mitochondrial respiratory chain located in the inner mitochondrial membrane consists of
four complexes (complexes I–IV) and complex V, which is directly involved in ATP
synthesis (DiMauro and Schon, 2003; Taylor and Turnbull, 2005). The terminal complex of
mitochondrial respiratory chain, complex IV or cytochrome c oxidase (COX), is where over
90% of oxygen is converted to water. Complex IV is targeted and can be irreversibly
inhibited by nitric oxide, found in multiple sclerosis lesions, depending on its concentration
and duration of exposure (Smith and Lassmann, 2002). In inflammatory environments, the
activity of mitochondrial respiratory chain complexes may be impaired through reactive
oxygen species-mediated post-transcriptional modification and nitration of the subunits as
well as damage to the only non-nuclear DNA, or mitochondrial DNA, also to be present
within axons (Lu et al., 2000; Wei et al., 2002; Qi et al., 2006). Defects of mitochondrial
respiratory chain complexes and depletion of mitochondria not only cause an energy deficit
but may increase the susceptibility of axons to excitotoxic injury through impaired calcium
handling capacity (Rizzuto and Pozzan, 2006; von Kleist-Retzow et al., 2007).
There is increasing evidence implicating mitochondria in the pathogenesis of multiple
sclerosis. Mitochondrial respiratory chain complex I and complex III activity is reduced in
non-lesional motor cortex, where a number of nuclear DNA-encoded transcripts of
mitochondrial proteins are decreased (Dutta et al., 2006). There is oxidative damage to
mitochondrial DNA in chronic active white matter lesions, with an associated decrease in
complex I activity (Lu et al., 2000). Interestingly, complex IV activity and mitochondrial
DNA copy number are increased in chronic active lesion homogenates and within normal
appearing grey matter neurons, respectively, possibly as a compensatory mechanism (Lu et
al., 2000; Blokhin et al., 2008). We recently identified a defect in the main catalytic subunit
of complex IV, COX-I, within acutely demyelinated axons in pattern III and Balo’s type MS
lesions (Mahad et al., 2008). In this study we analysed mitochondrial density and complex
IV activity in active and inactive lesions in chronic (progressive) multiple sclerosis. Our data
suggest that the deficiency of complex IV activity may play a major role in axonal
degeneration in active lesions in this condition. However, the mitochondrial mass and
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complex IV activity are increased in inactive demyelinated lesions, possibly reflecting a
compensatory reaction to the increased energy demand of chronically demyelinated axons.
Methods
Autopsy tissue and classification of lesions
The brain and spinal cord tissue blocks, snap frozen in isopentane and stored at −70°C, from
multiple sclerosis cases and controls were obtained from the UK multiple sclerosis tissue
resource, London and Newcastle Brain Bank, UK (Table 1). Sixteen blocks with
macroscopic lesions from posterior frontal lobe of nine multiple sclerosis cases and six
blocks with macroscopic lesions from cervical and/or thoracic spinal cord of five multiple
sclerosis cases were characterized based upon distribution of Luxol Fast Blue (LFB) and
staining for proteolipidprotein and HLA-D expression in cryostat sections (10 μm
thickness). The chronic active or slowly expanding and chronic inactive lesions were
identified as previously described (van der Valk and De Groot, 2000). The cause of death for
multiple sclerosis cases was pneumonia (n = 7), cardiac failure (n = 1) or sepsis (n = 2) and
for controls was either cardiorespiratory failure/arrest or pneumonia. The Newcastle and
North Tyneside Local Research Ethics Committee approved the study (205/Q0906/182).
Immunohistochemistry
The cryostat sections (10 μm thickness) from snap frozen tissue blocks were air dried for 60
min. The sections were briefly (5 min) fixed in 2% paraformaldehyde prior to antigen
retrieval using EDTA for 1 min, incubation in 2% hydrogen peroxide, blocking in normal
goat serum and immunostaining using avidin-biotin-horseradish peroxidase complex (ABC)
and 3,3-diaminobenzidine as previously described (Table 2).
For double and triple immunofluorescent labelling, the snap frozen sections were prepared
as for immunohistochemistry, without hydrogen peroxide, and subclass specific secondary
antibodies directly conjugated with fluorochromes (Alexa fluor 488, 568 or 633) were used
from molecular probes (Invitrogen). The appropriate controls were performed to exclude
cross-reactivity and non-specific binding in double- and triple-labelling experiments.
COX and SDH histochemistry
Blocks of brain and spinal cord, snap frozen in isopentane and stored at −70°C, were
mounted for cryostat sectioning as for immunohistochemistry and the serial sections (10 μm
thickness) were air dried for 30 min and incubated in COX medium (100 mM cytochrome c,
4 mM diaminobenzidine tetrahydrochloride and 20 mg/ml catalase in 0.2 M phosphate
buffer, pH 7.0) at 37°C for 55 min (Clark et al., 1997; Mahad et al., 2008). Following COX
histochemistry, axons and mitochondria were identified using double immunofluorescent
histochemistry, as described above, in the same section. To detect complex II activity serial
cryostat sections were incubated in SDH medium (130 mM sodium succinate, 200 μM
phenazine methosulphate, 1 mM sodium azide, 1.5 mM nitroblue tetrazolium in 0.2 M
phosphate buffer, pH 7.0) at 37°C for 40 min, once the sections were washed following
incubation in COX medium for 50 min. For the identification of complex IV activity within
axons, the sections were immunofluorescently labelled using antibodies against
neurofilaments and amyloid precursor protein, as described above (Table 2), following
completion of COX histochemistry. The stained sections were dehydrated in 70%, 90% and
100% ethanol prior to mounting in aqueous medium.
COX electron microscopy
Immediately following tissue harvest, small pieces of tissue with ~1 mm thickness were
dissected from the spinal cord lesions and normal appearing white matter and fixed in 4%
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glutaraldehyde for 15 min. To determine complex IV activity the pieces of tissue were then
washed in phosphate buffer prior to incubation in COX medium (100 mM cytochrome c, 4
mM diaminobenzidine tetrahydro-chloride and 20 mg/ml catalase in 0.2 M phosphate buffer,
pH 7.0) at 37°C for 90 min. The pieces of tissue were washed in phosphate buffer, fixed
with 4% glutaraldehyde overnight at 4°C and then post-fixed with 1% osmium tetroxide in
0.1 M phosphate overnight (Kirkinezos et al., 2005). The samples were dehydrated in a
series of acetone prior to embedding in Epoxy resin. Ultrathin sections without any further
staining were examined with a Philips CM100 EM (Biomedical EM unit, Newcastle
University).
Western blotting
To prepare homogenates, white matter from CON (n = 6), normal appearing white matter (n
= 6) and chronic inactive multiple sclerosis lesions (n = 6) from posterior frontal cortex was
carefully removed from cryosectioned slides (20 μm thickness) using a scalpel and
homogenized in buffer containing 250 mM sucrose, 2 mM HEPES and 0.1 mM EDTA.
Samples were diluted in sample buffer (0.5 M Tris–HCl buffer, pH 6.8, 20% Glycerol, 4%-
SDS, 0.1% Bromophenol blue) containing 2% β-mercaptoethanol, incubated for 30 min at
37°C and separated on a 15% SDS polyacrylamide gel at 150 V. Proteins were transferred
electrophoretically to 0.45 μm polyvinylidene fluoride membranes (Millipore Corporation,
USA) for 3 h at 300 mA in CAPS buffer (2.2 g CAPS, 900 ml of 10% methanol, pH 11.0) at
4°C. The membranes were blocked overnight in 5% milk-TTBS and incubated for 90 min
with primary antibodies against β-actin, porin, phosphorylated as well as total
neurofilaments, syntaphilin and complex II 70 kDa subunit (Table 2). After three washes
with TTBS, the membranes were incubated for 90 min with horseradish peroxidise-
conjugated polyclonal rabbit anti-mouse antibody (DAKO, Denmark) diluted in 5% milk-
TTBS. The secondary antibody was detected using ECL Plus Western Blotting detection
system (GE Healthcare, UK). The signal was visualized using STORM 860 scanner (GE
Healthcare, UK) and the peak heights of bands were determined using Image Quant TL
software (GE Healthcare, UK).
Neuron culture
We used neurons differentiated from a wild-type mouse embryonic stem cell line CC9.3.1
(gift of Dr Allan Bradley, Sanger Centre, Cambridge, UK). Undifferentiated mouse
embryonic stem cells were maintained on 0.1% gelatine coated flasks (Greiner Bio-One) in
Glasgow modified Eagle’s medium (Invitrogen), 10% foetal calf serum (Biosera)
supplemented with 2 mM L-glutamine (Invitrogen), 1 mM sodium pyruvate, 1% non-
essential amino acids (Invitrogen) and 0.1 mM 2-mercaptoethanol (Invitrogen). Embryoid
bodies were generated by transferring mouse embryonic stem cells onto Petri dishes in
mouse embryonic stem medium, which was changed every 2 days (Day 2, Day 4, Day 6 and
Day 8). A total of 1 μMtrans-retinoic acid (Sigma) was added at Day 4 and Day 6 of
embryoid body formation. At Day 8, embryoid bodies were trypsinized and cells were plated
on 6-well tissue culture plates containing coverslips coated with 10 μg/ml poly-D-lysine
(Sigma) and 2 μg/ml laminin (Sigma) at a density of 8 × 105 cells per well. The cells were
cultured in Neurobasal medium + bFGF (Invitrogen), Dulbecco’s modified Eagle’s medium
(Sigma), 1.6% B27 (Invitrogen), 1 mM sodium pyruvate, 2 mM L-glutamine (Invitrogen),
1% non-essential amino acids (Invitrogen), 0.2% N2 (Invitrogen) and 10 ng/ml of bFGF
(Peprotech) for 2 days. On Day 3, the medium was replaced by Neurobasal medium without
bFGF and cell cultured for further 4 days with media changed every 2 days. The
experiments were performed on 15 days old mature neurons. Less than 5% of the population
consisted of GFAP-positive (astrocytes) or OX-42 positive (microglia) cells.
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The mature neurons were exposed to a range of concentrations of sodium azide (1, 10 and
100 μM), a specific inhibitor of complex IV, alone or glutamate alone (1, 10 and 100 μM)
for 1, 2, 4, 8 and 16 h. Furthermore, in parallel experiments glutamate in varying
concentrations (1, 10 and 100 μM) was added to mature neurons for the last 1 h of sodium
azide exposure at each time point. Using ethidium homodimer exclusion method, previously
described, we determined a sublethal concentration of sodium azide and glutamate, either in
isolation or together, as 10 μM of sodium azide alone for 2 h, 100 μM of glutamate alone
for 1 h and the addition of 100 μM glutamate to the second 1 h of the 2 h 10 μM sodium
azide exposure. The experiments were repeated on four separate occasions for each time
point and the cover slips were immediately fixed in 2% paraformaldehyde for 10 min prior
to immunofluorescent double labelling with β-tubulin and APP or non-phosphorylated NF
(SMI32). The number of ethidium homodimer positive cells, judged by fluorescent
microscopy, was <1% and not significantly different at these sublethal concentrations and
exposure times. The exposure of neuron cultures to 10 mM sodium azide inhibited complex
IV activity by 36% as determined using spectrophotometry and when corrected for citrate
synthase activity (Taylor and Turnbull, 1997).
Microscopy
For the analysis of complex IV activity within axons, firstly, bright field grey scale images
of COX histochemistry were obtained using a 100× oil lens and, secondly,
immunofluorescent double labelling of axons (SMI31, SMI32 or APP) was captured in
exactly the same field and plane of focus (Zeiss Axioplan) in each area. In brain lesions, all
large axons (>2.5 μm in diameter and at least 50 μm in length) identified by
immunofluorescent labelling were captured whereas in the spinal cord three adjacent 100×
images perpendicular to the longitudinal axis of axons were captured in each area due to the
relative mass of longitudinally sectioned phosphorylated neurofilament (SMI31) positive
axons compared with the posterior frontal lobe sections. For the analysis of complex IV
activity to correlate with microglial/macrophage density, four bright field grey scale images
of COX histochemical and HLA immunohistochemical staining per area were obtained at
20× magnification in serial sections. The exposure time of grey scale images were kept
constant between areas as well as sections. The myelinated and demyelinated areas were
located based on the lesion classification in serial sections.
For the analysis of mitochondrial mass within axons in tissue sections, triple-labelled
sections with porin, syntaphilin and axonal marker (SMI31, SMI32 or APP) were imaged
using a 63× oil lens and Leica laser scanning microscope (Heidelberg, Germany). One
micrometre thick individual optical sections were taken through the tissue sections (10 μm).
The minimum number of optical sections was combined to track longitudinally sectioned
axons. FITC, TRIC and Cy5 channels were imaged sequentially and the offset and gain were
kept constant during imaging of all sections. A x–z optical section was taken through each
large axon (>2.5 μm in diameter and at least 50 μm in length) to ensure the axonal
localization of porin and syntaphilin reactive elements. All large axons in brain sections and
three adjacent sections perpendicular to the longitudinal axis of axons in spinal cord were
captured for each area.
In neuron cultures, axons were identified with immunofluorescently labelled β-tubulin
(Rhodamine) and imaged using a 63 × oil lens (Zeiss Axiovert microscope). Fifty β-tubulin
positive axons (>100 μm in length) were imaged in adjacent fields per cover slip with the
SMI32 (FITC) or amyloid precursor protein (FITC) immunofluorescent labelling related to
β-tubulin positive axons captured by keeping the exposure time for FITC images constant.
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Quantitation of axonal complex IV activity and mitochondrial mass
To identify the complex IV active elements within large axons, the outline of the
immunofluorescently labelled axons (SMI31, SMI32 or APP) was superimposed on the
bright field image of COX histochemistry. The area occupied by complex IV active
elements was determined as a percentage of the total area of the large (>2.5 μm in diameter
and at least 50 μm in length) morphologically intact (without terminal ovoids or beading)
axons. The complex IV active elements within axons were subjected to further analysis with
respect to their intensity using densitometry and Zeiss Axiovision version 4.6. Densitometric
analysis of COX histochemical product is a valid means of assessing complex IV activity in
tissue sections (Hevner et al., 1995; Mahad et al., 2008). For the correlation of complex IV
activity with microglial/macrophage density, the densitometric value of entire 20× grey
scale images of COX histochemical staining was determined with the densitometric value of
normal appearing white matter, as an internal control, subtracted from the corresponding
value of lesion.
In confocal images, the area of porin reactive elements within x–y images of large axons, as
a percentage of axonal area, was determined. The axonal location of porin elements was
confirmed in x–z images. The myelinated and demyelinated axons were identified based on
the lesion classification in serial sections. The selection of long (50 μm or more) axonal
segments were based on establishing morphological integrity as well as minimizing the
identification of false positive segments lacking mitochondrial activity or elements because
of the naturally discontinuous distribution of mitochondrial elements and variability in inter-
mitochondrial distance within axons.
In neuron culture, the fluorescence intensity of FITC-labelled amyloid precursor protein
(APP) or SMI32 related to the β-tubulin positive unmyelinated axons (Rhodamine) was
densitometrically determined in 50 axons per coverslip for each of four separate
experiments. The mean densitometric value over the outline of 100 μm or longer β-tubulin
positive axonal segments was used to quantitate SMI32 and amyloid precursor protein
immunofluorescent intensity. The background densitometric value in bright field images for
complex IV activity and immunofluorescent images for amyloid precursor protein and
SMI32 reactivity was determined and subtracted from the axonal densitometric values in
order to correct for variation in the background intensity between sections.
Statistics
Parametric tests and SPSS version 14 were used for comparison of complex IV activity and
porin immunoreactivity between demyelinated and myelinated axons as well as
unmyelinated axons exposed to sodium azide and glutamate, in vitro.
Results
As mitochondrial defects are considered important in the pathogenesis of multiple sclerosis
lesions and axonal degeneration (Lu et al., 2000; Dutta et al., 2006) we studied
mitochondrial activity and mass in chronic active and inactive lesions. We then investigated
the implications of mitochondrial dysfunction, in particular complex IV, for nerve impulse
transmission and axonal viability.
A complex IV defect is present in amyloid precursor protein and SMI32 immunoreactive
injured demyelinated axons
We studied mitochondrial respiratory chain complex IV activity in relation to axonal injury.
As previously described we detected a number of amyloid precursor protein or SMI32
reactive injured axons in active and, to a lesser extent, inactive areas of chronic lesions (Fig.
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1) (Ferguson et al., 1997; Trapp et al., 1998; Kornek et al., 2000). The linear segments of
amyloid precursor protein and SMI32 positive demyelinated axons without signs of acute
transection or terminal ovoids in the brain and spinal cord multiple sclerosis tissue are
deficient in complex IV activity, which is not due to the absence of mitochondria (Fig. 1F–
I). The complex IV defect in injured axons in chronic lesions was confirmed by the
quantitation of the area occupied by as well as the intensity of complex IV active elements
(Fig. 2 and Table 3). Within amyloid precursor protein positive axons complex IV activity
was significantly lower compared with SMI31 positive myelinated and demyelinated axons
in control white matter and inactive areas of chronic lesions, respectively. Furthermore,
there was a significant reduction in complex IV activity in SMI32 compared with SMI31
positive chronically demyelinated axons in inactive areas of chronic lesions (Fig. 2 and
Table 3). While axonal mitochondrial mass determined by porin reactivity was unchanged in
amyloid precursor protein positive axons, SMI32 reactive chronically demyelinated axons
revealed a significant decrease in mitochondrial content (Table 3). These data are consistent
with a complex IV defect in amyloid precursor protein positive demyelinated axons,
whereas the lack of complex IV activity in SMI32 relative to SMI31 reactive chronically
demyelinated axons appears to be partly due to mitochondrial depletion.
Mitochondrial respiratory chain complex IV activity is increased in chronic inactive areas
of multiple sclerosis lesions
To our surprise, histochemistry revealed the activity of mitochondrial respiratory chain
complex II and complex IV to be increased particularly in the inactive centre of chronic
active and in inactive lesions (Figs 1A–C and 3C–D). The punctate complex IV active
elements, typical of mitochondria, were more prominent in terms of density and intensity in
chronically demyelinated areas (Fig. 3E and G) compared with normal appearing white
matter (Fig. 3F and H). When the complex IV active elements within large axons (diameter
>2.5 μm) were identified using histochemistry and immunofluorescent labelling of SMI31, a
proportion of demyelinated axons were abundant in mitochondrial elements with intense
complex IV activity (Fig. 3I–N). Amyloid precursor protein or strong SMI32 reactivity was
not detected in demyelinated axons with abundant complex IV active elements.
Furthermore, COX electron microscopy showed mitochondria with greater complex IV
activity in demyelinated axons in relatively inactive chronic lesions compared with
myelinated axons in the normal appearing white matter (Fig. 4).
The quantitation of the area occupied by the complex IV active elements as a percentage of
the total area of large axons confirmed the apparent increase in complex IV activity within
SMI31 positive chronically demyelinated axons as significantly different from myelinated
axons (Fig. 2). Furthermore, the intensity of complex IV active elements, when determined
using densitometry, showed greater complex IV activity per mitochondrial element in
chronically demyelinated compared with myelinated SMI31 positive axons (Table 3). Based
on the 95% confidence intervals of complex IV activity in myelinated axons in control white
matter, 55 and 59% of chronically demyelinated axons in multiple sclerosis brain and spinal
cord, respectively, contained the increased complex IV activity (Fig. 2). The increase in
complex IV activity in multiple sclerosis tissue appears also to involve the myelinated
segments of axons in normal appearing white matter of brain but not spinal cord (Fig. 2).
The mean diameter of demyelinated (4.47 μm) and myelinated (4.21 μm) axons analysed
was not significantly different.
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Mitochondrial mass, syntaphilin and phosphorylated neurofilaments are increased within
morphologically intact demyelinated axons in chronic inactive areas of multiple sclerosis
lesions
Given the changes in complex IV activity in relation to acute axonal injury and chronic
demyelination, we determined the mitochondrial mass in lesions and within axons using
western blotting and triple-labelled immunofluorescent histochemistry with monoclonal
antibodies against porin, a voltage gated anion channel expressed on the outer membrane of
all mitochondria (Dutta et al., 2006; Mahad et al., 2008), syntaphilin—a mitochondrial
docking protein expressed specifically within axons—(Kang et al., 2008) and SMI31,
respectively (Table 2 and Fig. 5). In chronic lesions, western blotting identified a 1.6-fold
increase (n = 5 and P = 0.006) in porin and 3.2-fold increase (n = 4 and P = 0.002) in
syntaphilin compared with control white matter from the same area (Fig. 5A–C).
Numerous mitochondrial elements, which are abundant in chronic lesions, were distributed
parallel to the longitudinal axis of axons (Fig. 5D and G). The syntaphilin positive
mitochondrial elements were prominent in chronic lesions compared with normal appearing
white matter (Fig. 5E and H). As expected syntaphilin positive mitochondrial elements were
not present in MHC class II positive macrophages or microglia. The triple labelling of porin,
syntaphilin and SMI31 and confocal microscopy showed that the demyelinated axons are
abundant in mitochondria relative to myelinated axons (Fig. 5D–I). When the area of axonal
porin reactive elements as a percentage of axonal area was determined using confocal
microscopy in large axons (>2.5 μm) with at least 50 μm continuous segments, SMI31
positive demyelinated axons in chronic lesions contained a significantly greater
mitochondrial mass compared with the myelinated axons (Table 3). Based on the 95%
confidence intervals of porin immunoreactivity within myelinated axons in control white
matter, 34.8% and 37.1% (32 out of 92 and 49 out of 132) of chronically demyelinated
axons in multiple sclerosis brain and spinal cord, respectively, showed the increase in
mitochondrial mass.
Mitochondria interact with high molecular weight neurofilament-H, in particular to the
phosphorylated side-arms of neurofilament-H (Wagner et al., 2003). The phosphorylation
status of neurofilament-H side-arms influences the interaction between neurofilament and
mitochondria in a manner that is dependent on the metabolic activity of mitochondria
(Wagner et al., 2003). We found a significant increase in phosphorylated neurofilament-H
compared with normal appearing white matter (1.83-fold in six cases, P = 0.033) and control
(1.86-fold in six cases, P = 0.02) white matter when corrected for β-actin (Fig. 5J). When the
same tissue homogenates were used to detect total neurofilament-H, the change in total
neurofilament-H in multiple sclerosis lesions (1.35-fold increase in six cases, P = 0.58)
compared with normal appearing white matter was not significant (Fig. 5K). The ratio
between phosphorylated and total neurofilament-H, both corrected for β-actin, identified a
significant increase in the phosphorylation status of neurofilament-H in chronic lesions
compared with control white matter (1.70-fold increase in six cases, P = 0.025) and normal
appearing white matter (1.34-fold increase in six cases, P = 0.048).
Complex IV activity correlates inversely with microglial and macrophage density in
chronic multiple sclerosis lesions
Based on the facts that axonal injury correlates with inflammation, microglia/macrophages
are a source of reactive oxygen species (ROS) in multiple sclerosis lesions and complex IV
is susceptible to ROS-mediated damage, we determined the density of microglia and
macrophages in active (n = 8) and inactive (n = 22) areas of chronic lesions and correlated
with complex IV activity in serial sections. There was a significant inverse correlation
between the density of microglia/macrophages and global (axonal and glial) complex IV
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activity in demyelinated areas relative to normal appearing white matter when
densitometrically assessed at 20 × magnification (Fig. 6). The active rims of chronic lesions
contained significantly less complex IV activity (densitometric value of −1.55 ± 2.54,n = 8)
relative to the inactive areas of chronic lesions (13.15 ± 8.83, n = 22 and P < 0.001). The
complex IV activity in chronic lesions did not correlate with post-mortem interval, which
varied from 6–12 h (Table 1).
The complex IV dysfunction involves Na+/K+ ATPase -positive demyelinated axons
We determined the implications of a complex IV defect for nerve impulse transmission by
identifying the population of Na+/K+ ATPase α-1 positive axons in chronic lesions, as Na+/
K+ ATPase is energy dependent (Young et al., 2008). When demyelinated axons were
identified using total neurofilament reactivity and captured in random 100× fields from the
chronic inactive lesions (n = 6), the range of percentage complex IV active elements within
Na+/K+ ATPaseα-1 positive demyelinated axons was 0–8.54 with an average of 2.56 (Fig.
7). Furthermore, there was a number (19 out of 59) of Na+/K+ ATPaseα-1 positive
demyelinated axons without any complex IV active elements (Fig. 7).
Inhibition of complex IV augments glutamate-mediated axonal injury, in vitro
As the next step, we investigated the implication of complex IV inhibition for axonal
integrity and susceptibility to excitotoxic damage in vitro, given the association between the
lack of complex IV activity and axonal injury. We exposed neuronal cultures to sublethal
concentrations of sodium azide, a specific inhibitor of complex IV, which reduced the
activity by 36%, or glutamate as well as sodium azide followed by glutamate (Fig. 8).
Interestingly, the inhibition of complex IV alone led to a slight but significant decrease in
amyloid precursor protein immunoreactivity compared with controls, which may reflect
reduced fast axonal transport in a state of partial energy deficiency (Fig. 8G). However,
there was a striking synergistic effect on excitotoxic axonal injury (amyloid precursor
protein and SMI32 immunoreactivity) when complex IV was inhibited preceding exposure
to glutamate (Fig. 8F and G).
Discussion
We determined the mitochondrial respiratory chain complex IV activity and mitochondrial
mass within axons in multiple sclerosis and control brain and spinal cord tissue, based on the
hypothesis that mitochondrial defects lead to axonal degeneration and energy demand is
greater in demyelinated axons. We then investigated the implications of a complex IV defect
for axonal degeneration in vitro.
The exceptionally high rate of axonal injury in actively demyelinating multiple sclerosis
lesions is well established (Ferguson et al., 1997; Trapp et al., 1998; Kornek et al., 2000). In
chronic lesions, axonal degeneration correlates with the extent of inflammation and leads to
axonal loss through a slow burning process (Dutta and Trapp, 2007). The pathological signs
of axonal injury include intra-axonal accumulation of proteins such as amyloid precursor
protein, a marker of fast axonal transport block, and de-phosphorylation of neurofilaments.
The amyloid precursor protein positive segments of demyelinated axons located in active
rims and relatively inactive centre of chronic lesions harbour mitochondria with a complex
IV defect. Furthermore, the morphologically intact chronically demyelinated axons with
strong non-phosphorylated neurofilament reactivity showed a significant decrease in
complex IV activity, mostly due to mitochondrial depletion, compared with SMI31 positive
chronically demyelinated axons. Mitochondrial depletion as a result of axonal transport
disturbance is reported in microglia induced neuritic beading in vitro, motor neuron death in
an in vivo mutant SOD-1 model of motor neuron disease, which targets mitochondria, as
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well as in syntaphilin knockout axons, affecting calcium signalling and leading to synaptic
short-term facilitation (Takeuchi et al., 2005; De Vos et al., 2007; Kang et al., 2008).
For the first time, we report a significant increase in complex IV activity as well as
mitochondrial mass within approximately half of large chronically demyelinated SMI31
positive axons located in relatively inactive areas of chronic (active and inactive) multiple
sclerosis lesions in brain and spinal cord, respectively, compared with large myelinated
axons. The increase in complex IV activity in mitochondria isolated from chronic lesions
compared with normal appearing white matter provides support for the histochemical
findings of this study (Lu et al., 2000). The lack of structural changes, in terms of
accumulation of amyloid precursor protein and de-phosphorylation of neurofilament, in the
chronically demyelinated axons with increased complex IV activity as well as previous
reports of similar findings in unmyelinated axons with substantial densities of sodium
channels and demyelinated axons suggest the above mitochondrial changes related to
demyelination as a potentially adaptive rather than a pathogenic process (Hildebrand and
Waxman, 1983; Bristow et al., 2002; Barron et al., 2004; Andrews et al., 2006). The
mitochondrial adaptations to metabolic demand include changes in mitochondrial mass and
activity (Waxman, 1982; Bristow et al., 2002; Hollenbeck and Saxton, 2005). Indeed, an
adaptive change in axonal mitochondria in multiple sclerosis lesions offers an explanation
for the predominant loss of small diameter demyelinated axons, which have relatively less
volume to surface area or ‘energy to ions’ ratio compared with large diameter axons
(DeLuca et al., 2004; Waxman, 2006b). Whilst local lesion environmental factors are likely
to be the major drivers of such a mitochondrial change a role for neurons, which have been
shown to contain increased mitochondrial DNA, is suggested by the significant increase in
complex IV activity within myelinated axons in multiple sclerosis brain (Blokhin et al.,
2008).
The increase in complex IV activity in relation to demyelination is associated with an
increase in mitochondrial mass within axons. In addition, the majority of mitochondrial
elements within axons contain syntaphilin, which was recently identified as an axon specific
mitochondrial-docking protein (Kang et al., 2008). Syntaphilin immobilizes axonal
mitochondria through targeting of outer mitochondrial membrane by the carboxyl terminal
tail and binding with microtubules. The immunohistochemical detection of syntaphilin is a
reliable tool to identify immobile mitochondria within axons and provides further support
for the increased mitochondrial mass within demyelinated axons in multiple sclerosis. The
detection of syntaphilin immunoreactivity without porin may be due to the amplification of
syntaphilin and not porin and the presence of syntaphilin unbound to mitochondria within
demyelinated axons. Mitochondria also interact with neurofilaments dependent on their
metabolic activity and the phosphorylation status of neurofilaments, with energized
mitochondria binding to more phosphorylated neurofilaments (Wagner et al., 2003). There is
an increase in hyperphosphorylated neurofilaments in acute lesions and phosphorylated
neurofilaments immunoreactivity in chronic lesions (Shintaku et al., 1988; Petzold et al.,
2008). In this study we have identified a significant increase in phosphorylated relative to
total neurofilament-H in chronic multiple sclerosis lesions compared with adjacent
myelinated areas in multiple sclerosis and corresponding areas in control brains using
western blotting. Whether the interaction between mitochondria and phosphorylated
neurofilaments affects mitochondrial movement and activity within axons is not known.
However, the increase in syntaphilin in chronic lesions suggests that mitochondria within
large chronically demyelinated axons are relatively immobile compared with myelinated
axons and decreased mitochondrial movement may partly determine their accumulation
within demyelinated axons (Kang et al., 2008). In addition, mitochondrial fission, fusion as
well as biogenesis within axons may contribute to the increase in axonal mitochondrial mass
following demyelination (Amiri and Hollenbeck, 2008).
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Interestingly, not all chronic multiple sclerosis lesions showed an increase in complex IV
activity, with the active rims of chronic active lesions showing significantly less complex IV
activity compared with relatively inactive lesion centre. Inflammation is a potent inducer of
mitochondrial dysfunction and activated microglia and macrophages are sources of nitric
oxide and reactive oxygen species in lesions (Qi et al., 2006). Nitric oxide and reactive
oxygen species may irreversibly inhibit complex IV activity through nitration of catalytic
subunits, post-translational modification as well as oxidative damage to mitochondrial DNA
(Lu et al., 2000; Smith and Lassmann, 2002; Wei et al., 2002). In EAE, nitration of
mitochondrial respiratory chain complex I and complex IV subunits and reduced ATP
synthesis was mediated intrinsically within the central nervous system preceding the arrival
of inflammatory infiltrate (Qi et al., 2006). Furthermore, the inhibition of complex IV is
recognized in microglia induced neuritic beading, in vitro (Takeuchi et al., 2005). We
recently identified a complex IV defect within acutely demyelinated axons in cases with
fulminant multiple sclerosis and Balo’s type lesions, where microglial activation is an early
feature and innate immunity is implicated early in the pathogenesis (Marik et al., 2007;
Mahad et al., 2008). In this study, the inverse correlation between the global complex IV
activity and density of microglia/macrophages (HLA-positive cells) identifies innate
immunity (microglia) as a probable determinant of complex IV dysfunction in chronic
lesions from brain and spinal cord. On a technical aspect, the above inverse correlation
suggests the inclusion of microglial complex IV active elements overlapping axons in bright
field images as an unlikely contributor to the apparent increase in axonal complex IV
activity in chronic lesions.
In the 1960s, Hodgkin and colleagues identified complex IV as an essential component for
efflux of sodium by Na+/K+ ATPase and maintenance of resting membrane potential
(Hodgkin, 1964). Nitric oxide, an inhibitor of complex IV, has been elegantly demonstrated
to cause conduction block (Redford et al., 1997). Hence, the mitochondrial respiratory chain
complex IV is necessary for nerve impulse transmission. The lack of sodium channels and
Na+/K+ ATPase on a subset of chronically demyelinated axons with the implications for
nerve impulse transmission has been suggested as a contributor to disease progression in
multiple sclerosis (Black et al., 2007; Young et al., 2008). We identified a complete lack of
complex IV activity within a number of Na+/K+ ATPase positive chronically demyelinated
axons, which will not be able to maintain their resting membrane potential. We propose
mitochondrial complex IV dysfunction as a cause of conduction failure during the
progressive stage of multiple sclerosis, possibly accounting for part of the persistent
neurological impairment, and identify mitochondria as a potential therapeutic target.
Besides an energy defect, a disturbance in calcium handling capacity is an important
consequence of mitochondrial respiratory chain defects (Rizzuto and Pozzan, 2006; von
Kleist-Retzow et al., 2007). In multiple sclerosis, the loss of inhibitory interneurons and
their processes increases excitatory neurotransmission and firing of demyelinated axons
(Dutta et al., 2006; Clements et al., 2008). Furthermore, the increase in mitochondrial mass
infers a greater role for mitochondria as an intracellular source of calcium buffering in
demyelinated compared with myelinated axons in multiple sclerosis (Nikolaeva et al., 2005).
Using sublethal doses of sodium azide, a specific inhibitor of complex IV, and glutamate in
neuron cultures we show an augmentation of glutamate induced axonal injury judged by
amyloid precursor protein accumulation and non-phosphorylated neurofilaments. The in
vitro findings in this study, which is unlikely to be an indirect affect on axons by glial cells
due to the paucity of glia in cultures, together with the degeneration of axons conducting
impulses at physiological frequencies when exposed to nitric oxide, suggest that a complex
IV defect within demyelinated axons in multiple sclerosis may increase the susceptibility to
excitotoxicity (Smith et al., 2001).
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Our study has identified a mitochondrial respiratory chain complex IV defect, possibly
mediated by microglia and macrophages, within injured axons and an increase in
mitochondrial mass and complex IV activity within chronically demyelinated axons in
inactive areas of chronic lesions. The complex IV defect is likely to impair Na+/K+ ATPase
activity, resting membrane potential and nerve impulse transmission, possibly accounting
for part of the persistent neurological disability in patients with progressive multiple
sclerosis. Furthermore, a complex IV defect increases the susceptibility to glutamate-
mediated axonal injury. Thus, preservation of mitochondrial respiratory chain activity within
demyelinated axons may have a therapeutic benefit in terms of improving the function and
prevention of axonal degeneration in patients with multiple sclerosis.
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Figure 1.
Complex IV activity within injured demyelinated axons. (A–E) In the active rim of chronic
active multiple sclerosis lesions, identified by the loss of Luxol Fast Blue (A) and presence
of MHC class II positive cells (B) in serial sections, the complex IV activity is at an
intermediate level compared with normal appearing white matter and relatively inactive
lesion centre (C). Surprisingly complex IV activity is increased in the inactive area of
chronic lesions. There are a number of ovoid shaped structures containing intense complex
IV activity in the active rim (C and insert). When the same serial section used for COX
histochemistry (C) is immunofluorescently labelled for amyloid precursor protein (APP)
(D), the complex IV active ovoid structures are APP-positive (D, E). However, not all APP
reactive ovoids show complex IV activity (red, E). (F–I) The APP-positive linear segments
of demyelinated axons without terminal ovoids (red in F and G) in chronic lesions are
devoid of complex IV activity, brown punctate elements apparent at 100× magnification (F,
arrows). The lack of complex IV activity in APP-positive demyelinated axons is not due to
the lack of mitochondria as shown by the presence of porin reactive elements (green) in x–y
and x–z confocal images (G arrows and inserts). In a separate chronic lesion, the
immunofluorescent labelling of non-phosphorylated neurofilaments (SMI32) identifies an
injured demyelinated axon (red in H and I) which also lacks complex IV active elements (H,
arrowheads). The SMI32 (red) reactive axon lacking complex IV active elements contain
numerous porin (green) reactive elements (I, arrowheads). x– y and x–z; confocal images of
APP and porin immunoreactivity in x–y and x–z planes. Asterisk indicates inactive area of
chronic multiple sclerosis lesion.
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Figure 2.
Quantitation of complex IV activity within axons in brain and spinal cord. (A, B) The
percentage area of complex IV active elements within large (>2.5 μm) axons indicates a
significant decrease in complex IV activity within acutely injured APP positive axons in
brain (A) and spinal cord (B) multiple sclerosis lesions compared with SMI31 positive
myelinated axons. Furthermore, SMI32 positive injured demyelinated axons from inactive
areas of chronic lesions contain significantly less complex IV activity compared with SMI31
positive demyelinated axons from the same area. The complex IV activity within SMI31
positive chronically demyelinated axons are significantly greater compared with myelinated
axons in normal appearing white matter and control white matter of brain and spinal cord.
The SMI31 positive myelinated axons in normal appearing white matter contain
significantly greater complex IV activity compared with SMI31 positive myelinated axons
in control white matter in brain (A) but not spinal cord (B). The dotted line indicates the
upper range of 95% confidence interval based on complex IV activity in myelinated axons
from control white matter. The number of large axons analysed is indicated within
parentheses. The values are means ± SD of percentage area of complex IV active elements
within large axons. *P < 0.001.
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Figure 3.
Mitochondrial respiratory chain complex IV and complex II activity in chronic multiple
sclerosis lesions. (A–D) Serial sections of a posterior frontal tissue block containing a
chronic active multiple sclerosis lesion (A, arrow), identified by the loss of Luxol Fast Blue
(LFB, A) and a rim of inflammatory activity (HLA reactivity, B), shows increased activity
of mitochondrial respiratory chain complex IV (C) or cytochrome c oxidase (COX) and
complex II (D) or SDH throughout the lesion compared with normal appearing white matter.
The complexes IV and II active mitochondria are enriched in the cortex (ctx). (E–H) The
complex IV active mitochondrial elements are prominent within axons as well as glia in
relatively inactive areas of chronic lesions in the brain (E) as well as spinal cord (G) lesions
compared with adjacent normal appearing white matter (F and H). (I–N) The chronically
demyelinated large diameter (>2.5 μm) axons in brain (outlined in E) and spinal cord
(outlined in G), identified by SMI31 reactivity (J and M) within chronic lesions, contain
intense complex IV active elements (I and L) as evident in the superimposed images (K and
N). Most complex IV active elements are punctate (I and L), typical of mitochondria, but
others are elongated aligning the longitudinal axis of axons (I).
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Figure 4.
COX electronmicroscopy. (A,B) Electronmicroscopy of chronic multiple sclerosis lesions
following COX histochemistry shows mitochondria with dark cristae and membranes
abundant in complex IV activity (A, arrows) within demyelinated axons compared with
mitochondria (B, arrowheads) in myelinated axons in normal appearing white matter.
Mahad et al. Page 18
Brain. Author manuscript; available in PMC 2013 March 22.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 5.
Mass and docking of axonal mitochondria and phosphorylation status of neurofilaments in
chronic multiple sclerosis lesions. (A–C) Mitochondrial mass, judged by porin
immunoreactivity, is increased throughout chronic multiple sclerosis lesions, as apparent in
a serial section of the lesion in Fig. 1. Western blots of porin, a voltage gated anion channel
expressed on all mitochondria, and a subunit of complex II (SDH70 kDa or SDHA), which
is entirely encoded by nuclear DNA, shows a 1.6-fold increase in mitochondrial mass in
chronic lesions compared with control white matter (n = 5, P = 0.006). (B). Western blots of
syntaphilin, an axon specific mitochondrial docking protein, shows a 3.2- and 1.8-fold
increase (n = 4 P = 0.002) in chronic lesions compared with normal appearing white matter
and controls, respectively (C). (D–I) Porin (green) and syntaphilin (red) reactive elements in
triple immunofluorescently labelled confocal images are abundant in chronic lesions (D and
E) compared with normal appearing white matter (G and H). The majority of syntaphilin
reactive mitochondrial elements are located within SMI31 positive (blue) demyelinated
axons (F), whereas myelinated SMI31 positive axons in the normal appearing white matter
contain strikingly less porin and syntaphilin reactive elements (I). Interestingly syntaphilin
immunoreactivity within demyelinated axons does not always co-localize with porin
immunoreactive elements (F). (J, K) Western blots of phosphorylated and total
neurofilaments (NF) in chronic lesions show an increase in phosphorylated neurofilament-H
in lesions compared with normal appearing white matter and control white matter (J), which
is partly due to an increase in total neurofilaments (K). When corrected for β-actin and total
neurofilament-H there is a 1.7-fold increase (P = 0.025, n = 6) in phosphorylated
neurofilament-H in chronic lesions compared with control white matter. CON WM; control
white matter. L = lesion. MS = multiple sclerosis; NAWM or N = normal appearing white
matter; NF = neurofilaments.
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Figure 6.
Inverse correlation between global complex IV activity within multiple sclerosis lesions and
the density of microglia/macrophages. When the global complex IV activity was
densitometrically determined in 20× images, there is a significant inverse correlation (P =
0.001) between complex IV activity and the density of HLA reactive microglia and
phagocytic macrophages. Furthermore, complex IV activity in the active rims or expanding
edge of chronic active lesions (unfilled circles) is significantly lower (P < 0.001) compared
with the inactive areas of chronic lesions (filled circles). The cell density is per 20× field.
The densitometric values are corrected for background variation using normal appearing
white matter.
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Figure 7.
The complex IV dysfunction involves chronically demyelinated axons with Na+/K+ ATPase
α-1 reactivity. (A–C) As a proportion of chronically demyelinated axons lacks Na+/K+
ATPase (Young et al., 2008), necessary for sodium extrusion from the axon, complex IV
activity was determined within Na+/K+ ATPase α-1 positive chronically demyelinated
axons. There are Na+/K+ ATPase α-1 positive demyelinated axons, identified with total
neurofilaments, in inactive areas of chronic lesions showing a lack of complex IV active
elements (arrowheads). Furthermore, there are axons with bulbous expansions lacking
complex IV activity as well as axons lacking both Na+/K+ ATPase α-1 and complex IV
activity (arrows).
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Figure 8.
Complex IV inhibition augments glutamate-mediated axonal injury, in vitro. (A–E) The
axons in control neuron cultures, differentiated from mouse embryonic stem cells, in vitro,
express both β-tubulin (A, green) as well as phosphorylated neurofilaments (SMI31 in a,
red). The neuronal cultures were exposed to sublethal concentrations and durations of
sodium azide (10 μM sodium azide for 120 min), a specific complex IV inhibitor, or
glutamate (100 μM glutamate for 60 min) alone as well as sodium azide and glutamate
sequentially (addition of 100 μM glutamate to the second 1 h of the 2 h 10 μM sodium azide
exposure). Within β-tubulin positive unmyelinated axons not exposed to sodium azide or
glutamate (B and D, red) there is minimal SMI32 (non-phosphorylated neurofilaments) and
APP (amyloid precursor protein) reactivity (B and D, green). In contrast, neuron cultures
exposed to sublethal concentrations of sodium azide and glutamate show abundant SMI32
(C, green) and APP (E, green) reactivity within β-tubulin positive (C and E, red)
unmyelinated axons. (F, G) When acute injury of unmyelinated axons, in vitro, was
densitometrically analysed the 10 μM sodium azide, which reduced complex IV activity by
36%, led to a significant decrease in APP immunoreactivity in β-tubulin positive axons (F).
When the neuronal cultures were sequentially exposed to sodium azide there is a striking
synergistic increase in axonal injury, judged by both SMI32 (F) and APP (G)
immunoreactivity. *P < 0.001. Two hundred axons were analysed in four separate
experiments for each group. CON = control; NaN3 = sodium azide.
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Table 2
Details of antibodies used for immunohistochemistry and Western blots
Antigen Target Antibody type Source
PLP Proteolipid protein Mouse IgG Serotec
HLA-DP, DQ,
DR Human leukocyte antigen Mouse IgG1 Dako
SMI31 Phosphorylated neurofilaments Mouse IgG1 Vector Laboratories
SMI32
Non-phosphorylated
neurofilaments Mouse IgG1 Vector Laboratories
TNF Total neurofilaments Rabbit polyclonal Millipore
β-APP Amyloid precursor protein
Mouse IgG1/rabbit
polyclonal Millipore
Syntaphilin Syntaphilin Rabbit polyclonal Santa Cruz Biotechnology
Porin
Mitochondrial transmembrane
protein Mouse IgG2b
Molecular probes,
Invitrogen
SDHA II SDH 70 kDa subunit Mouse IgG1
Molecular probes,
Invitrogen
β-Tubulin Class III β-tubulin Rabbit Polyclonal Covance
β-Actin β-Actin Mouse IgG1 Sigma
Na+/K+ATPase Na+/K+ATPase α-1 Mouse IgG1 Upstate biotechnology
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